Company Overview of S*BIO Pte Ltd.
S*BIO Pte Ltd., a biotech company, focuses on the discovery, research, and clinical development of small molecule drugs for the treatment of cancer in Singapore. The company’s pipeline comprises JAK2 inhibitors, such as SB1518 for leukemia/myelofibrosis, lymphoma, and polycythemia; and SB1578 for RA/psoriasis. Its pipeline also includes SB939, a histone deacetylases for MDS/AML+combo, prostate cancer, sarcoma, pediatric tumor, and myelofibrosis; SB2602, a mTOR inhibitor; SB2343, a mTOR/PI3K inhibitor; and SB1317, a CDK/Flt3 inhibitor. The company was founded in 2000 and is based in Singapore. S*BIO Pte Ltd. operates as a subsidiary of Chiron Corporation Limited.
1 Science Park Road
#05-09 The Capricorn
Singapore Science Park II
Singapore, 117 528
Founded in 2000
65 6827 5000
65 6827 5005
Key Executives for S*BIO Pte Ltd.
Similar Private Companies By Industry
|Cell Sciences Pte Ltd.||Asia|
|SG Austria Pte. Ltd.||Asia|
|Pharmalogicals Research Pte. Ltd.||Asia|
|Compass Foods Pte Ltd||Asia|
|EPIC Bio Pte. Limited||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact S*BIO Pte Ltd., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.